Neuland Laboratories Limited (NSE:NEULANDLAB)
India · Delayed Price · Currency is INR 16,992
+83 (0.49%)
Jun 3, 2026, 3:29 PM IST
Neuland Laboratories Market Cap
Neuland Laboratories has a market cap or net worth of 217.99 billion as of June 3, 2026. Its market cap has increased by 34.96% in one year.
Market Cap
217.99B
Enterprise Value
217.45B
Revenue
20.23B
Ranking
n/a
PE Ratio
59.89
Stock Price
16,992.00
Market Cap Chart
Since December 18, 2000, Neuland Laboratories's market cap has increased from 335.14M to 217.99B, an increase of 64,944.19%. That is a compound annual growth rate of 28.96%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 2, 2026 | 217.40B | 11.55% |
| Dec 31, 2025 | 194.89B | 10.65% |
| Dec 31, 2024 | 176.13B | 159.63% |
| Dec 29, 2023 | 67.84B | 216.90% |
| Dec 30, 2022 | 21.41B | 7.77% |
| Dec 31, 2021 | 19.86B | 41.44% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Ipca Laboratories | 382.51B |
| Gland Pharma | 377.69B |
| Ajanta Pharma | 363.70B |
| Wockhardt | 349.83B |
| Emcure Pharmaceuticals | 323.29B |
| Piramal Pharma | 226.93B |
| Eris Lifesciences | 188.74B |
| NATCO Pharma | 167.16B |